Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03050086 · ClinicalTrials.gov registry record · Phase 1
Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea
A Phase 1 study, sponsored by BioPharmX.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT03050086: Completed Phase 1 study, sponsored by BioPharmX.
NCT03050086 is a Phase 1 study that has completed, run by BioPharmX. The registered enrollment target is 30 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03050086, a Phase 1 study, has completed, sponsored by BioPharmX.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
An open label feasibility study using BPX-04 topical minocycline gel in papulopustular rosacea.
Primary Outcome
papules, pustules and erythema
Interventions
- DRUG BPX-04 1% minocycline topical gel
- DRUG BPX-04 2% minocycline topical gel
- DRUG BPX-04 vehicle topical gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-03-29 |
| Est. Completion | 2018-06-19 |
| Phase | Phase 1 |
What the finished NCT03050086 record still lists
NCT03050086 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 3 interventions - of which BPX-04 1% minocycline topical gel is the first listed.
NCT03050086 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03050086 about?
NCT03050086 is a clinical study titled "Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea". An open label feasibility study using BPX-04 topical minocycline gel in papulopustular rosacea.
What is the current status of trial NCT03050086?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2017-03-29. Estimated completion is 2018-06-19.
What interventions are being tested in trial NCT03050086?
The interventions under investigation include: BPX-04 1% minocycline topical gel (DRUG), BPX-04 2% minocycline topical gel (DRUG), BPX-04 vehicle topical gel (DRUG).
Who is sponsoring clinical trial NCT03050086?
This trial is sponsored by BioPharmX, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03050086's enrollment target sits among peer trials
30 1332nd of 2000 higher than 561 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI